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 A PROSPECTIVE STUDY OF COMPARING  IMMEDIATE 
VERSUS DELAYED REMOVAL OF URINARY CATHETER 
FOLLOWING ELECTIVE CESAREAN DELIVERY 
INTRODUCTION : 
Cesarean delivery rates have risen steadily. Maternal mortality 
associated cesarean delivery is rare because of improved anesthetic care, use of 
antibiotics prior to surgery to prevent infections. But there is some preventable 
morbidity still prevalent like urinary tract infections and voiding difficulties. 
Interventional strategies should be intensified to reduce the risk of these 
morbidities to prevent from postoperative complication. 
             Complications of cesarean section include bowel and bladder injury, 
blood loss. The use of catheter during cesarean section is to view bladder flap 
easily, to avoid bladder injury and postoperative urinary retention. 
One of the preoperative preparations for cesarean delivery is the 
placement of an indwelling Foley urethral catheter.  
                 According to each person the duration of catheter use varies 
postoperatively and standard evidence for duration of catheter is not available.  
Even though there are lots of studies and policies, CAUTI remains a significant 
problem in many of the tertiary centers. Further larger studies are needed to 
identify the risk factors, to reduce the rate of CAUTI.      
                 
 
 
There were several studies suggesting that routine use of urethral 
catheter in all cesarean sections is not necessary. Early catheter removal is 
practiced to reduce the incidence of CAUTI, as well as improves other 
parameters like early ambulation, early first voiding time, shortens hospital stay 
and decrease the patients discomfort after surgery. 
  
 
 
AIM 
To find out whether immediate removal of urinary catheter can be usefully 
implemented following elective cesarean section in our population. 
OBJECTIVES 
PRIMARY OBJECTIVE: 
 To compare the outcomes of immediate and delayed urethral catheter removal 
following elective cesarean section. The measures are 
1. To compare the occurrence of urinary tract infection. 
2. To compare recatheterisation 
3. To compare first voiding time 
4. To compare ambulation 
SECONDARY OUTCOMES: 
Patient’s discomfort 
 
 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
CESAREAN DELIVERY defines the birth of a fetus via laparotomy 
and then hysterectomy. The word cesarean is derived from the Latin word 
caedare, which means to cut. 
HISTORY OVERVIEW: 
 Cesarean section dates from antiquity, since the reign of Numa 
Pompilius in Rome (715-672 BC).It is usually employed in the hope of 
obtaining a living child when the mother was dead or so near to death that 
maternal survival was not a practical consideration.The term cesarean section 
was first used by James Guillimeau. The first cesarean delivery was 
documented in 1020 AD.1 
  The Italian obstetrician Porro in 1876 devised the technique of 
amputation of the uterus at the internal os and fixation of the cervical stumps in 
the lower end of the abdominal wound. 
  In 1882, the German gynecologist Max Sanger introduced classical 
cesarean and advocated closure of the uterine incision using gut sutures which 
reduced the risk of hemorrhage and need for cesarean hysterectomy. He has 
rightly called as the father of modern cesarean section.2 
 In 1821, a disastrous attempt at extra peritoneal cesarean section was 
made by Ritgen, in which the patient died although the child was born alive. 
 
 
At the beginning of 20th century, Frank in 1907 developed an extra 
peritoneal operation for cases in which uterus was infected. Kronig in 1912 
modified the technique and suggested that success does not lie in the extra 
peritoneal approach and introduced the transperitoneal lower segment cesarean 
section. 
It was Munro Kerr in 1926 that 1st described the lower segment 
transverse uterine incision and popularized the procedure (3) 
 
INCIDENCE OF CESAREAN SECTION: 
 The incidence of cesarean section is rising in most parts of the world. 
Cesarean rates were higher in women with previous cesarean (70.8%) 
and with breech presentation (89.8%) (4). 
There are many reasons for the increase in cesarean section rates over 
the last 40years including differences in organization and management of labor, 
higher expectations, poor outcomes, medico- legal cases and ultimately more 
recently maternal choice, which in most cases driven by a dissatisfaction of the 
previous care in labor. 
 Epidemiological changes have also taken place with an older age group 
of women giving birth, many with higher body mass indices and some co-
existing medical conditions. 
 
 
Attempts have made to standardize processes at institutional, local, 
regional, national and international levels6 but have had only limited success.7 
  There is little doubt that cesarean section rates will vary in different 
institutions nationally and internationally and do not necessarily relate to poor 
quality care, particularly if cesarean rates were the only outcomes that were 
analysed. 
Study by Potter JE, Berquo E, Perpetuo IH et al states that incidence 
also varies immensely between public and private institutions, cesarean section 
rates up to 70% reported from private set-ups.5 
 Recently two studies done by Sibanda T, Fox R, Draycott TJ,et al states 
that women and professionals are interested in safety and quality; safety and 
quality is related to outcome and outcome guides processes. In theory at least, 
it should be simpler to standardize measurement of outcomes and events 8, 9 
rather than processes. 
 Advances in CS techniques, anesthesia, antibiotics and transfusion have 
transformed a CS from a procedure most commonly carried out as a last resort 
in the past to a relatively safe way of delivering a baby.10, 11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cesarean section is the delivery of the fetus via laparotomy and 
hysterectomy.(removal of fetus from uterus by abdominal and uterine 
incisions).Cesarean sections have been classified in many ways .One common 
method is by their urgency 1) planned or elective 2) Emergency section. 
ELECTIVE INDICATIONS FOR CESAREAN SECTION: 
I. MATERNAL: 
1) Contracted pelvis 
2) Pelvic soft tissue tumors – cervical atresia 
3) Bony deformities affecting the pelvis 
4) Vertebral column deformities – kyphosis ,scoliosis 
5) Previously poor obstetric outcome 
6) Previously traumatic delivery 
7) Previously infertility 
8) Maternal request 
 
II. FETAL 
1) Malpresentations 
- Breech 
- Transverse lie 
- Unstable lie persistent at term 
- First twin with malpresentation 
2) Fetal macrosomia 
3) HIV positive mother 
  
ABSOLUTE INDICATIONS: 
1) Pelvic contraction of moderate to severe degree 
2) Fibroid in the lower uterine segment or cervix 
3) Ovarian cyst incarcerated in the pelvis 
4) Cancer cervix 
5) Pelvic bone tumors 
6) Cervix or vaginal strictures that is indivisible or undilatable. 
 
III. PLACENTAL 
1) Major degrees of placenta praevia 
2) Vasa praevia 
 
 
ADVANTAGES OF CESAREAN DELIVERY: 
 Reduced incidence of perineal pain 
 Reduced incidence of urinary incontinence 
 Reduced incidence of uterovaginal prolapse 
COMPLICATIONS FOLLOWING CESAREAN SECTION: 
 Abdominal pain 
 Injury to bowel and bladder 
 Increased risk of rupture uterus and maternal death 
 Neonatal respiratory morbidity 
 Hysterectomy 
 Thromboembolic disease 
 Increased duration of hospital stay 
 Ante partum or intrapartum intrauterine deaths in future pregnancies 
 Patients with a previous history of cesarean delivery are more prone to 
develop complications like placenta previa and adherent placenta during 
future pregnancies.   
 
 
 
 
 
 
 
Patient choice in cesarean delivery: 
Women have taken a more active role in their obstetrical care, some 
request elective cesarean delivery. Data regarding the true incidence of 
cesarean delivery on maternal request (CDMR) are limited. 
Reasons for requested cesarean delivery include 
1) To avoid any risk to the fetus 
      2)   Because of delivery pain 
3) Protection of pelvic floor support and convenience. Thus the debate 
surrounding CDMR includes its medical rationale from both a maternal 
and fetal neonatal standpoint, the concept of informed free choice by the 
women, and the autonomy of the physical in offering this choice. 
 National Institute of Health (2006) held a state – of – the – science 
conference on Cesarean Delivery on Maternal Request. It is noteworthy that 
most of the maternal and neonatal outcomes examined had insufficient data to 
permit such recommendations.69 
American college of Obstetrics and Gynecologist (2013) concluded that 
data comparing planned cesarean and planned normal vaginal delivery were 
minimal and thus should be interpreted cautiously.70 
The panel was able to draw a few conclusions from existing information. 
Cesarean delivery on maternal request should not be performed before 39 
weeks gestation unless there is an evidence of fetal lung maturity.    
 
 
Finally it should not be motivated by the unavailability of effective pain 
management.   
PREVIOUS CESAREAN SECTION: 
Pregnant women with a previous section may be offered either planned 
VBAC or ERCS (Elective repeat cesarean section).VBAC stands for vaginal 
birth after cesarean, which refers to vaginal birth following one or more 
cesarean births.   
.Criteria for vaginal birth after cesarean section: 
1) Previous history of one uncomplicated lower segment transverse 
cesarean section 
2) Low transverse incision on the uterus 
3) Pelvis is adequate 
4) Patient is willing for vaginal birth after cesarean section 
5)  Facilities for continuous monitoring of fetal heart rate during labor 
6) No other contraindication for CS 
7) Previous history of vaginal birth particularly VBAC   
8) VBAC should be undertaken in settings where facilities for emergency 
CS are present. 
    
 
 
 
 
Advantages of VBAC: 
 Prevention of surgery related complications including deaths 
 Prevention of blood loss 
 Prevention of infection 
 Prevention of injury to various organs including bowel, urinary bladder, 
etc. 
 Prevention of thromboembolism. 
 Breast feeding is generally easier after a vaginal birth 
 Vaginal birth is usually associated with reduced health care costs in 
comparison to cesarean births. 
 VBAC is also associated with lower fetal mortality and morbidity in 
comparison to elective repeat cesareans. 
Contraindications for VBAC: 
Previous history of uterine rupture 
Previous history of J- shaped or an inverted T- shaped uterine incision 
Previous history of high vertical classical cesarean section(CS),with 
uterine incision involving almost the whole length of the uterine corpus  
History of previous three or lower segment uterine scars in the past 
Presence of an obstetric indication for cesarean including cephalopelvic 
disproportion, placenta previa, malpresentation, etc   
Limited resource setting, where it might not be possible to continuously 
monitor the patient  
Patient refuses to give consent for VBAC. 
   
 
 
 Risk for VBAC: 
 If VBAC turns out to be unsuccessful, an emergency CS may be 
required 
 There is a risk of scar dehiscence and rupture 
 Increased risk of maternal and perinatal mortality in case of scar rupture 
 Failure of vaginal trail may end up in requirement for an emergency CS. 
It may also cause uterine rupture or pelvic floor dysfunction.  
  Advantages conferred by vaginal birth after cesarean section: 
 VBAC helps in avoiding the potential future maternal consequences 
related to multiple cesarean deliveries 
 Helps in avoidance of major abdominal surgery, which is associated 
with lower rates of complications such as hemorrhage, infection, etc. 
and a shorter recovery period. 
 RCOG has reported that attempting VBAC helps in reducing the risk of 
the baby having respiratory problems after birth (risk of 2-3% with 
planned VBAC and 3-4% with ERCS). 
             Factors associated with a reduced success rate of vaginal birth 
after cesarean   VBAC:                                       
VBAC at or after 41 weeks of gestation  
Birth weight greater than 4000g  
No epidural anesthesia 
 
 
Previous preterm cesarean births 
Cervical dilatation of less than 4cm at the time of admission 
History of previous cesarean birth less than 2 years back 
Advanced maternal age 
Non white ethnicity 
Short stature and a male infant 
 
INDICATIONS NOT REQUIRING CESAREAN SECTION: 
Preterm birth 
Twin pregnancy with first twin having a cephalic presentation 
Intrauterine growth restriction 
Infection with hepatitis B virus 
Infection with hepatitis C virus 
Recurrent genital herpes in the third trimester. 
FACTORS REDUCING THE LIKELIHOOD OF CESAREAN BIRTH 
 Continuous support during labor from women with or without prior 
training 
 Induction of labor beyond 41 weeks 
 
 
 Use of partogram with a 4 hour action line to monitor progress of labor 
in women with spontaneous labor having an uncomplicated singleton 
pregnancy 
 Involvement of consultant obstetricians in the decision making process 
for cesarean delivery 
 In case of abnormal heart rate pattern, use of fetal blood sampling for 
detecting the cases of suspected fetal acidosis.  
 
 
The most important complication associated with CS is the possibility of 
scar rupture during future pregnancies, especially if given trial for vaginal 
delivery. 
Symptoms of impeding scar rupture during the labor include the following: 
 Dull suprapubic pain or severe abdominal pain, especially if persisting 
in between the uterine contractions 
 Slight vaginal bleeding 
 Bladder tenesmus or frequent desire to pass urine 
 Unexplained maternal tachycardia 
 Maternal hypotension or shock 
 Abnormal FHR pattern 
 Scar tenderness 
 Interruption of previously efficient uterine contractions 
On vaginal examination, there may be a failure of normal descent of 
presenting part and the presenting part remaining high up. There also 
sudden loss of station of the presenting part. 
The diagnosis of scar rupture is ultimately confirmed at the time of 
emergency cesarean delivery or postpartum laparotomy. 
 
 
 
 
One of the preoperative preparations for cesarean delivery is the 
placement of an indwelling Foley urethral catheter. 
FOLEY CATHETER: 
Named after its designer, (Frederic Foley) is a flexible tube passed 
through urethra and into the bladder to drain urine. It is the most common type 
of indwelling urinary catheter. The tube of a Foley catheter has two separated 
channels, or lumens, running down its length. 
One lumen – opens at both ends and drains into collection bag. 
Other lumen – valve on the outside and connects to a balloon at the tip. 
  The balloon is inflated with sterile water when it lies inside the bladder 
to stop it from slipping out. Foley catheters are commonly made from silicone 
rubber.  
 
 
 
Draining the bladder is performed by inserting the Foley catheter into 
the urethra or crating artificial track i.e. suprapubic catheterization. 
The female urethra is short, being 40mm in length, tubular structure that 
has the sole purpose of conducting urine from the bladder to the outside of the 
body. It develops from the endoderm and the surrounding splanchnic 
mesoderm of the urogenital sinus. At 7 weeks gestation, the cloaca divides into 
the urogenital sinus and the rectum with the development the urorectal septum. 
The female urethra is typically developed by the 12th gestational week. 
 
 
The developed urethra is a 4cm tubular structure that begins at the 
bladder neck and terminates at the vaginal vestibule. It is supplied by spongy 
cylinder and is designed to provide continence.  
Foley catheter is expressed in French i.e. Fr or FG which is the 
circumference in mm. smallest catheter - 12-16 Fr 
Larger catheter -18 Fr. 
URINARY TRACT INFECTIONS IN PREGNANCY: 
            UTI are the most common bacterial infections encountered during 
pregnancy. Beginning from 6th week and peak during 22-24th weeks of 
pregnancy women develop ureteric dilatation, which remains until delivery. 
           Increased bladder volume and decreased bladder tone, along decreased 
urethral tone, contribute to increased urinary stasis and ureterovesical reflux 
Causative organism: 
Escherichia coli – 80-90% - originate from fecal flora that colonizes the 
periurethral area. (Ascending infection). 
Klebsiella, Enterobacter, Proteus species – most remaining cases. 
Enterococcus faecalis and group B streptococcus – gram positive clinically 
important pathogens. 
Staphylococcus saprophyticus, - community acquired organism-persistent or 
recurrent. 
Chlamydia infections – 30% nonbacterial infections. 
 
 
PATHOGENESIS: 
Approximately 90% of Escherichia coli strains that cause nonobstructive 
pyelonephritis have adhesins such as P- and S- fimbriae. These are cell surface 
protein structures that enhance bacterial adherence and thereby, virulence 
.These adhesins promote binding to vaginal and uroepithelial cells through 
expression of the Pap gene that encodes the P- fimbriae tip and by production 
of toxins and other virulence factors.    
UTI has three principal presentations: 
1) Asymptomatic bacteriuria 
2) Acute cystitis 
3) Pyelonephritis  
ASYMPTOMATIC BACTERIURIA: 
  Refers to actively multiplying bacteria within urinary tract in women 
who have no symptoms. 
            Guito VT in a Cochrane review states that the prevalence of 
asymptomatic bacteriuria in pregnant women is 5-10%.12 
Colony forming units per ml of urine.13 If asymptomatic bacteriuria is 
not treated, about 25-30% of infected women will subsequently acute 
symptomatic infection during pregnancy with increased maternal morbidity and 
mortality. 
 
 
Routine urine testing for bacteriuria is recommended early in pregnancy 
at the first antenatal visit.15 
A midstream, clean catch urine specimen should be tested to avoid the 
possibility of cross – contamination from urethra and vagina. The presence of 
more than one organism in culture usually indicates contaminated specimen. 
The specimen should be sent as soon as possible. It should be refrigerated at 
4degree C, if it cannot be transported. 
DIPSTICK ANALYSIS:    
COMPONENTS OF THE URINE DIPSTICK: 
TEST NORMAL POSITIVE RESULTS 
INDICATES 
LEUKOCYTES Negative Infection ,Allergy 
NITRITES Negative Gram – Negative 
Bacteria 
PROTEIN Negative Renal inflammation, 
Allergies 
GLUCOSE Negative Glucose spill - 
Diabetes, Allergy  
KETONES* Negative Energy from fats, not 
CHO’s  
UROBILINOGEN Negative Compromised 
conjugation of bile 
BILIRUBIN Negative Hemoglobin 
Destruction 
BLOOD Negative Infection, 
Hypertension, Menses 
HEMOGLOBIN Negative Cell damage – 
oxidation, Allergy   
 *The presence of ketones in urine indicates that body is utilizing fat as 
fuel and may also be indicative of abnormal carbohydrate metabolism.    
 
 
 
LEUKOCYTE   ESTERASE: 
Leukocyte esterase refers to enzymatic remnant of the white blood cells. 
It is predominantly found in granules of the azurophilic neutrophil.These 
granules possess proteins exhibit esterolytic activity. This reacts with an 
impregnated reagent to produce a positive result of blue color. Since the 
neutrophils are labile, leukocyte esterase denotes enzymatic remnants of cells 
which are not visible microscopically. 
      A positive leukocyte esterase thus denotes presence of significant number 
of neutrophils – either intact or lyses. Leukocyte esterase catalyses hydrolysis 
reaction to produce respective alcohols and acid components. 
 FALSE NEGATIVE RESULTS: 
1. Altered specific gravity, protein, glucose 
2. Boric acid 
3. Antibiotics like tetracycline, cephalexin, cephalothin 
4. High ascorbic acid content. 
FALSE POSTIVE RESULTS: 
1. contaminated urine with vaginal secretions 
2. An alternate for cellular sources of esterase 
3. In the presence of formalin and oxidizing agents. 
 
 
Nitrites: 
 
Gram negative bacteria like E.coli reduce nitrates – nitrites. 
Atleast a minimum duration of 4 hours of urinary stasis is required for 
the action of bacteria to breakdown nitrates. 
False positive results may occur if there is delay in testing the sample or 
in case of long standing sample. 
              Dipsticks measuring leukocyte esterase and nitrites have low 
sensitivity for screening for asymptomatic bacteriuria during pregnancy.16 
 
 
 
URINE CULTURE: 
Urine culture has been the gold standard. The laboratory must ensure 
that an appropriate, because a urine samples may be contaminated with the 
anterior urethral flora. The specimen must be processed as soon as receipt in 
the laboratory to avoid overgrowth of this flora. In case of any delay, sample 
may be refrigerated at 4-8◦c. Do not freeze it.       
The drawbacks are the time lag (results available after 24 to 74hours), 
even some organism takes even longer time to grow. 
 ADVANTAGES: 
1) Urine samples sent for culture and sensitivity to detect presence of 
pathogens that cause Urinary tract infections and determination of 
antibiotic sensitivities. 
      2) Urine culture sensitivity is the choice of treatment for UTI 
     3) It also helps whether treatment for UTI worked. 
CULTURE MEDIA: 
      The samples are inoculated on differential media such as MacConkey and 
colonies suspected of being a pathogen are selected and processed. Common 
pathogens include Escherichia coli, Enterococcus faecalis, Proteus spp., 
Klebsiella pneumonia, Pseudomonas aeruginosa. The samples are also 
 
 
inoculated on an enriched media such as Blood agar, for selection of Candida 
spp / Staphylococcal spp. 
      Non pathogenic micro flora of the perineum will not be identified and 
reported. These include – diphtherias and Bacillus spp. 
Urine samples processed for culture and sensitivity are 
1. Midstream clean – catch urine. 
2. Urine from patient with an indwelling catheter 
3. Urine obtained after using a straight in and out catheter 
4.  Suprapubic / cystoscopic aspirates. 
Samples are considered unsuitable for culture if 
1. Unrefrigerated urine >2hrs old 
2. 24 hours urine sample for bacterial culture 
3. Refrigerated urine sample > 24hours 
4. Foleys catheter tip and urine and urine from the bag of catheterized 
patient. 
5. Urine for anaerobic culture (only suprapubic aspirates accepted). 
6. Improper labeling of sample or no requisition slip. 
7. Sample in an unsterile container. 
 
 
 
 
MEDIA:   BA, MC, MHA ;inoculation loop 2mm size delivering 0.005 
ml of urine slides, cover slips, flame, inoculation hood, sterile saline antibiotics 
discs, Vitek 2 cards ,McFarland standard, PW tube, Biochemical sets and 
reagents, Incubator, discarding  jar. 
All specimen inoculations are processed in a biosafety cabinet class II 
2A.                               
DAY 1: 
Macroscopic appearance of urine (turbid, clear, and bloody) is noted in 
the register. 
In case of delay in processing store the specimen at 4◦c. 
Uncentrifuged urine is processed for both microscopy and culture. Urine is to 
be centrifuged and deposit used only for following requests: 
1. Microscopically observe ova of schistosoma haematobium or 
2. For culture of salmonella from urine. 
Microscopy: 
1. Wet preparation: Mix the urine sample well by swirling. Take a 
loopful of urine, and place on a clean, grease-free slide. Place a cover 
slip on this avoiding formation of bubbles. Observe under 100X (low 
power field) and 400X (high power field). 
 
 
Count number of pus cells, RBCs, epithelial cells/field. Pyuria is >3 
cells/high power field.54 
Note the presence or absence of bacteria. 
Yeast like cells, Trophozoites of Trichomonas vaginalis and ova of 
schistosoma haematobium may also be observed. 
GRAM STAINING: 
Gram staining is not routinely done. This may be done if a specific 
request for the same is received. 
 Mix the urine sample well by swirling, Take a loopful of urine, Smear 
on a clean grease free labeled glass slide, Air dry, heat fix, Perform Gram’s 
stain – observe under 1000X (oif –oil immersion field).  
Record the number of pus cells, epithelial cells and the Gram reaction & 
morphology of the organism / Oil immersion field, correlates to 1,00,000 
colonies or more by culture. One bacteria in gram stain = >105 CFU in 
culture. 
CULTURE: 
1. Media used: 5% sheep blood agar and MacConkey agar. 
2. Mix the urine thoroughly by swirling with the lid closed 
 
 
3. Loop (2mm) delivering 0.005ml of urine is used for culture. Dip the loop 
vertically into the urine, just enough to cover the loop. Ensure that a film of 
urine fills the loop with no bubbles to alter the calibrated volume. 
4. Half plate of medium is used per sample. Loopful of urine is spread over 
the surface agar plate as shown below. The loop is not reheated in between 
streaks on the same plate. 
  
 
 
 
Mid stream urine: 
*In case slow growing pathogens like Candida spp. or if inhibition by 
antibacterial is suspected, incubate for further 24 hours. 
CLEAN – CATCH MIDSTREAM URINE COLLECTION: 
This method helps protect the urine sample from germs that are normally 
found on vagina. The first urine of the day is preferred because bacterial levels 
will be higher. 
 
Number of colonies Report & Interpretation Action taken 
>105 colony forming 
unit(cfu/ml) of Gram 
negative bacilli (GNB) 
or >104 Gram positive 
cocci(GPC) or Candida 
spp 
 
 
Significant bacteriuria 
/candiduria 
Proceed with 
identification and 
antibiotic susceptibility 
testing. Report available 
on Day 3, with antibiotic 
sensitivity report.  
 
 
103 to 104 cfu/ml of 
GPC, Candida spp 
 
 
Significant bacteriuria/ 
candiduria 
Proceed with 
identification and 
antibiotic susceptibility 
testing. Report available 
on Day 3, with antibiotic 
sensitivity report. 
 2 morphotypes of 
isolates 
 
105 colony forming 
unit/ml (cfu/ml) of Gram 
negative bacilli (GNB) 
or 104 Gram positive 
cocci (GPC) or Candida 
spp. with Pyuria. 
 
 
Significant bacteriuria 
Proceed with 
identification and 
antibiotic susceptibility 
testing for each isolate. 
Report available on Day 
3, with antibiotic 
susceptibility.  
>/= 3 morphotypes Mixed urethral flora. 
Suggest repeat MSU 
sample to confirm. 
To be dealt on a case to 
case basis. 
No colonies Urine sterile after 24 
hours of incubation. 
Report sent on day 2* 
 
 
 Wash your hands before collecting the urine.  
 Women should spread open the folds of skin around her vagina with one 
hand, then use her other hand to clean the area around her vagina and 
urethra thoroughly. She should wipe the area from front to back to avoid 
spreading bacteria to the vagina that is normally found around the anus. 
RESULTS: 
         A urine culture is a test to detect and identify organisms (usually bacteria) 
that may cause UTI. 
    Normal: No bacteria or other organisms grow in the culture. The culture 
result is negative 
   Abnormal: organisms grow in the culture. The result is positive. 
    If more than one organism is grown in the culture usually it is a 
contaminated sample. 
What affects the test? 
Taking antibiotics or just finished taking them Taking diuretics. They 
may dilute your urine and reduce the number of bacteria in the sample. 
 
 
 
 
 
 
Catheterized patient 
Number of colonies Report &Interpretation Action taken 
Up to 3 morphotypes may be processed. Decide on case to case basis 
 
Suprapubic aspirate 
Number of colonies Report & Interpretation Action taken 
>102 colony forming 
unit/ml (cfu/ml) of 
Gram negative bacilli 
(GNB) or Gram positive 
cocci (GPC) or Candida 
spp.(any number). 
 
 
Significant bacteriuria 
Do antibiotic 
susceptibility testing for 
each isolate. Report 
available on Day, with 
antibiotic sensitivity 
report. 
 
>102 colony forming 
unit/ml (cfu/ml) of 
Gram negative bacilli 
(GNB) or Gram 
negative cocci (GPC) or 
Candida spp. 
 
Significant bacteriuria 
 
Proceed with 
identification 
and antibiotic 
susceptibility testing 
each isolate. Report 
available on Day 3, with 
antibiotic sensitivity 
report. 
 
 
 
Biochemical Identification and Antibiotic Susceptibility Testing: 
Antibiotic susceptibility testing for Enterobacteriaeceae / Pseudomonas 
spp / Enterococcus spp / Staphylococcus spp / as appropriate with biochemical 
tests for identification. 
Day 3: Report issued with identification, colony counts and AST. In 
case the isolate requires further biochemical testing, interim report with 
antibiotic susceptibility is issued. Final report is issued at a later date. 
Samples after examination are kept in the refrigerator at 4◦c till the 
report is dispatched. After dispatch of all the results pertaining to the sample, 
the sample along with the container is sent for autoclaving and disposal 
according to the biochemical waste management norms. The reported bacterial 
isolate (in a test-tube – TSI / peptone water) is stored in the refrigerator for a 
week. If any additional information, such as antibiotic susceptibility results for 
an additional antibiotic is required, should inform with a week (7 days after 
dispatch for that bacterial isolate).   
Media: 
1. BLOOD AGAR: 
INGREDIENTS: 
Peptone – 1gm 
Sodium chloride – 0.5gm 
Beef extract – 0.3gm 
Agar – 1.5gms 
 
 
Distilled water – 1000ml. 
 Mix all the ingredients and heat to dissolve adjust the ph 7.5-7.6 
sterilize by autoclaving media should be cooled to about 45-50◦c before blood 
is added. Add sterile sheep blood. Mix well and pour about 20ml of blood agar 
in each Petri dish. Human blood is not recommended for preparation of blood 
agar.  
Use: As an enriched medium and a differential medium for hemolytic 
organisms. Most common pathogens grow on it.  
 
 
 
 
 
 
 
 
CHOCOLATE AGAR: 
Chocolate agar is heated blood agar 
Sterile sheep blood = 7ml 
Nutrient agar = 100ml 
          Melt the Nutrient agar when the temperature is about 45-50◦c add the 
blood and mix well. After the addition of blood, heat in a water bath slowly, 
bringing up the temperature to 75◦c with constant agitation. Special care should 
be taken to avoid fluctuation in the temperature .Heating is continued till the 
blood changes to chocolate colour. The colour is very critical. Remove from 
the water bath. Cool to about 50◦c and pour 20ml into each plate with sterile 
precautions. Special care must be taken to avoid air bubbles. 
Use:  This is an enriched medium used for the cultivation of pathogenic 
Neisseria and H.influenza. 
     
 
 
 
MACCONKEY HIMEDIA: 
Peptic digest of animal tissue = 20.00gms 
Lactose                                    = 5gms   
Sodium taurocholate               = 0.04gms 
Neutral red                              = 20gms 
Agar                                        = 0.2 
Ph                                            = 7.4+ 
Suspended 55.0 grams in 1000ml distilled water heat to boiling to 
dissolve the medium completely. Sterilize by autoclaving at 15lbs pressure 
(121◦c) for 15 minutes. 
 
 
Use: For differentiation of enteric bacteria. The omission of sodium chloride 
prevents the spreading of Proteus colonies.  
 
MUELLER HINTON AGAR HIMEDIA: 
INGREDIENTS: 
Casein and hydrolysate = 17.50gms 
Beef heart infusion        = 2.00gms 
 Starch soluble               = 1.50gms 
Agar                               = 17.00gms 
Distill water                   = 1000ml 
Ph                                  = 7.3+ 
 
 
Directions: Suspend 38.0 grams in 1000ml distilled water. Mix well and 
boil to dissolve the medium completely. Sterilized by autoclaving at 15lbs 
pressure (121◦c) for 15 minutes. 
Use: Standard medium for antimicrobial susceptibility testing.
 
 
TREATMENT: 
Because of the dangers of maternal and fetal complications, acute care 
should focus on identifying and treating symptomatic and asymptomatic 
bacteriuria, along with ensuring that an alternate process is not the cause of the 
symptoms. 
 
 
 
Pregnant women should be treated when bacteriuria is diagnosed. The 
choice of the antibiotic should be guided by antimicrobial susceptibility testing 
whenever possible. If not, the most common infecting organisms and sensitive 
antibiotics should be considered. 
Nitrofurantoin seems to be the drug of choice for treatment of 
asymptomatic bacteriuria in pregnancy 17 
Empirical oral treatment for 10 days with nitrofurantoin macro crystals, 
100 mg at bedtime, is usually effective. 
Lumbiganon and associates in 2009 reported satisfactory results with a 
7- day oral course of nitrofurantoin, 100mg given twice daily. It is preferable to 
use a 7 – day regimen of antibiotics rather than short courses of during 
pregnancy 18  
Single dose – antimicrobial therapy has also been used with success for 
bacteriuria. The important caveat is that, regardless of the regimen given, the 
recurrence rate is approximately 30%.This may indicate covert upper tract 
infection and the need for longer therapy. 
          Ciprofloxacin, ceftriaxone and augmentin have been found to be the 
most effective antibiotics in urinary isolates.19 
         Schneeberger in 2012 states that periodic surveillance is necessary to 
prevent recurrent urinary infections.  
 
 
Lucas in his study states that recurrent bacteriuria we have had success 
with nitrofurantoin, 100mg orally at bed time for 21 days.20, 21 
Fosfomycin, a phosphonic acid derivative, is useful in the treatment of 
uncomplicated UTI’s caused by susceptible strains of E.coli and Enterococcus 
species. Fosfomycin is a US Food and Drug Administration (FDA) category B 
agent in pregnancy. 
ACUTE CYSTITIS: 
It is characterized by dysuria, urgency and frequency without evidence 
of systemic illness. Acute cystitis occurs in approximately 1% of pregnancies 
and may develop without antecedent asymptomatic bacteriuria. 
Usually there is Pyuria as well as hematuria. Microscopic hematuria is 
common. Although cystitis is usually uncomplicated, upper urinary tract may 
become involved with ascending infection. Women with cystitis respond 
readily to any of the several antibiotic regimens.  
Most of the three day regimens are 90% effective. 
For simple cystitis, a test for urine culture should be repeated after 1-2 
weeks of completion of therapy. Single dose therapy is less effective and if 
used, concomitant pyelonephritis must be confidently excluded.24 
Lower urinary tract symptoms with Pyuria accompanied by a sterile 
urine culture may be from urethritis caused Chlamydia trachomatis.59 
 
 
 
Mucopurulent cervicitis usually coexists and azithromycin therapy is effective. 
ACUTE PYELONEPHRITIS: 
Most common serious medical complication of pregnancy. It develops 
more frequently in the second trimester; nulliparity and young age are the other 
associated risk factors.23 
It is unilateral and right-sided in more than half the cases and bilateral in 
one fourth. Onset is abrupt fever and chills, pain in one or both lumbar regions. 
Differential diagnosis includes labour, chorioamnionitis, appendicitis, placental 
abruption and infracted myoma. 
            A retrospective descriptive hospital based study by Dawkins JC states 
that the risk of preterm labour and premature delivery is increased.24 
Maternal complications include anemia, septicemia, and transient renal 
dysfunction, pulmonary insufficiency.23, 25 
Respiratory compromise can be exacerbated by iatrogenic fluid overload 
and tocolysis with beta-agonist.26 
Maternal UTI has few direct sequelae because the fetal bloodstream 
infection is rare. However uterine hypo perfusion due to maternal dehydration, 
maternal anemia, and direct bacterial endotoxin damage to the placental 
vasculature may cause fetal cerebral hypo perfusion. 
 
 
            A retrospective population based study showed that UTI during 
pregnancy is independently associated with intrauterine growth restriction, pre-
eclampsia, preterm delivery, and cesarean delivery. 27 
Early and aggressive treatment is important in preventing complications 
of pyelonephritis. Hospitalization is indicated in patients with signs of sepsis, 
who are vomiting and unable to maintain hydration, and who are having uterine 
contractions. 
Intravenous hydration to ensure adequate urinary output is essential and 
antibiotics are started soon after clinical diagnosis. 
If clinical improvement is not seen despite appropriate antibiotic 
therapy, the possibility of a structural or anatomical abnormality should be 
investigated. Persistent infection may be caused by urolithiasis or less 
commonly congenital renal abnormalities or perinephric abscess. 
           In such cases, diagnostic tests may include renal ultrasound, plain 
abdominal radiograph and/or modified one shot pyelograms (a single 
radiograph obtained 30 min after contrast injection).    
Outpatient management of pyelonephritis in pregnancy is applicable in very 
few cases.  
PREOPERATIVE CARE FOR CESAREAN SECTION: 
Oral intake is stopped atleast 8 hours before the procedure. 
 
 
Recently performed hematocrit and blood grouping & typing are 
checked. If indirect Coombs test is positive then cross matching of blood must 
be kept ready. 
According to The American College of Obstetricians and Gynecologists, 
there are insufficient data to determine value of fetal monitoring before 
scheduled cesarean delivery in women without risk factors. Fetal heart sounds 
should be documented in the operating room prior to surgery. 68 
The risk of thromboembolism is increased with pregnancy and almost 
doubled in cesarean section. For women already receiving prophylaxis or those 
with increasing risk factors, prophylaxis is escalated. 
An indwelling catheter is placed to collapse the bladder away from the 
hysterotomy incision, to avert urinary retention secondary to regional 
anesthesia and to allow accurate postoperative measurement. 
Infection prevention:  
Febrile morbidity is frequent after cesarean delivery. Numerous good- 
quality trial have proved that a single dose of an anti – microbial agent given at 
the time of cesarean delivery significantly decreases infection morbidity. 
    Many women undergoes unscheduled cesarean delivery, this practice 
also significantly lowers the postoperative infection rate in women undergoing 
elective surgery 
 
 
Depending upon drug allergies, most recommend a single intravenous 
dose of a beta –lactam antimicrobial- either a cephalosporin or extended – 
spectrum penicillin derivative. 
A 1gm dose of cefazolin is an efficacious and cost effective choice.   
Pevzner and associates 72showed this dose may be inadequate for body 
mass index >40. In women with intravenous dose of amino glycoside is an 
alternative. A 900 mg Clindamycin is used for obese patients. 
American College of Obstetricians and Gynecologists recommend the 
prophylaxis be administered within 60 minutes prior to start of planned 
cesarean delivery.71 For emergent delivery, prophylaxis should be given as 
soon as feasible. 
Preoperative preparation of the anterior abdominal wall skin is effective 
to prevent wound infection. Either Chlorhexidine or Povidone - iodine 
solutions can be used. 
Risk factors for infection: 
Obesity 
Diabetes /Immunosuppressive disorder (like HIV) 
Chorioamnionitis (infection of the amniotic fluid and fetal membrane)  
Taking long term steroids 
Poor prenatal care 
 
 
Previous C-sections 
Long labor or surgery 
Several studies support the nonuse of catheterization or immediate 
removal of indwelling catheter in hemodynamically stable women to 
minimize UTI. 
          Onile et al. and his colleagues conducted a study in 200 women admitted 
for elective cesarean delivery. 
In one group of women catheter was removed immediately and in 
another group 24-h postoperatively. Urine samples were collected 
preoperatively and 72hours postoperatively. The samples were sent for urine 
microscopy, culture, and sensitivity. 
 There was lower incidence of urine analysis, urine culture sensitivity 
for patients in Group I compared than Group II.29, 30     
            Tambyah and Maki in their study stated that catheter insertion causes 
entry of organisms into the bladder and one of the risk factor for CAUTI is 
duration of catheter in place. Once catheterization is done the prevalence of 
UTI is found to be about 3-10%.31 
             Senanayake carried out a pilot prospective study in Colombo involving 
50 women. The volume of urine obtained at the beginning and at the end of 
cesarean section was measured using an indwelling catheter.  
 
 
In the main study, surgery was carried out without urethral 
catheterization on 344 women who had voided within previous hour. 
The results showed statistically significant rates between the two groups 
in urinary tract infection. (6%vs0.58%) (p < 0.05). Because of urinary retention 
two women required recatheterization. The rest of the women voided within a 
mean of 8.76hrs.33, 34, and 36 
       A randomized controlled study conducted by AM Nasr45 and his 
colleagues, among 420 gravid women undergoing cesarean were prospectively 
included one of two groups. In one group of patient catheter removed 
immediately and another group removed 12hr postoperatively. 
         Results included there were no significant differences regarding 
demographic characteristics, indications for cesarean, pre and post operative 
care, and intake of analgesics. 
Non – placement of indwelling urinary catheter during cesarean was 
more convenient to women with no increase in intraoperative complications, or 
urinary retention. The incidence of UTI was found to be significantly greater in 
the Catheterized Group (p<0.001). 
                Hany Abdel - Aleem also done a study by comparing the use of an 
indwelling catheter versus bladder drainage. There was no significant 
difference between the group in terms of urinary retention following CS, 
duration of hospital stay or the outcome of UTI.49, 50   
 
 
                  L Li, J wen and his collegues40 from their study stated that serious 
preoperative complications such as postpartum hemorrhage are more critical 
than urinary tract infection(UTI).The main disadvantage of catheterization is 
that increased  risk of UTI. Catheterization of the bladder for cesarean section 
is mainly to prevent any injury to the bladder, intraoperative difficulties and 
complications. 
      His study found that no catheter in cesarean section was associated with 
less UTI, no increase urinary retention or intraoperative difficulties. He states 
that  it is difficult to   confirm that non-catheterized group could cause more 
postpartum hemorrhage because no information is provided on the catheterized 
group. 
      Moreover hemorrhage might result from several causes and current 
evidence failed to certify between non-catheterization and hemorrhage.  
       S Acharya has done a prospective randomized controlled trial among 150 
patients. In that study 75 were catheterized, considered as one group and in 
another group 75 were not catheterized. 
They concluded that cesarean section can be done safely without 
urethral catheterization with reduced morbidities.40, 46   
           Joseph F and MD John 53 conducted a study in patients undergoing 
elective/repeat or emergent cesarean deliveries of 118 patients. All Patients 
encouraged to void within 30 minutes of the start of the surgery. They recorded 
the surgical time, time to first void and number of patients with urinary 
 
 
retention requiring in-out catheterization or placement of indwelling urinary 
catheter 
 Results showed that 118 patients underwent cesarean section, none of 
the cases showed bladder distention interfering with exposure of lower uterine 
segment. All patients were ambulated to the bathroom for their first void. There 
were no cases of UTI reported. Patients undergoing cesarean delivery 
(elective/repeat, or emergent) can safely avoid the use of an indwelling 
catheter.   
                 S Yong47 from his study found that as most cesarean sections are 
now performed under regional anesthesia. So there is more chance of 
postoperative urinary retention which will continue to be a significant postnatal 
problem. 
                   Li and colleagues concluded the paper, until newer regional 
anesthetic techniques are found to reduce post cesarean urinary retention, there 
will be still a role for routine catheterization, atleast in women undergoing 
regional anesthesia.  
                   Li and Wen’s40 done a systematic review, data extraction from all 
studies that met the inclusion criteria were independently reviewed by two 
reviewers. Totally 821 relevant articles kept as inclusion criteria 
He concluded that it doesn’t show evidence of no effect, but only that 
there is no evidence of the effect of the placement of an indwelling catheter for 
 
 
cesarean section. There is evidence that catheterization for no longer than 12 
hours doesn’t significantly increase the rate of urinary tract infections.40 
     Study by Akmal El Mazny, among 300 women who got admitted for 
primary or repeat elective cesarean sections were randomized into two equal 
groups. In Group A, the catheter was removed soon after the surgery, in Group 
II catheter delayed catheter removal was done (12hr postoperatively). 
Results of the study showed that postoperative significant bacteriuria (p 
=0.020), were significantly lower in group A compared with group B. 
So he concluded that immediate removal of urinary catheter after 
elective cesarean is associated with lower risk of urinary infection30 
           Ghoreishi performed a randomized study by randomly assigned 270 
women delivered by cesarean section. Comparison between catheterization and 
uncatheterized women were taken.135 women did not receive an indwelling 
catheter after cesarean delivery, 6 patients needed postoperative urinary 
retention. The ambulation time was 6.8h in the cases and 12.9 hours in the 
control group.  
He concluded that in uncatheterized group the hospital stay and 
ambulation time shortens.32 
  
 
  
 
 
MATERIALS AND METHODS 
The study was conducted in the department of Obstetrics and 
Gynecology, PSG hospitals, Coimbatore from June 2015 to May 2016.   
STUDY DESIGN: 
Prospective study 
STUDY POPULATION:  
This study consisted of prenatal women admitted to the antenatal wards 
for primary or repeat elective cesarean section. 
SELECTION CRITERIA: 
INCLUSION CRITERIA: 
-   All antenatal women for elective cesarean section. (Primary or repeat LSCS) 
EXCLUSION CRITERIA: 
 Urinary infection assessed clinically or by midstream urine samples 
 Significant vaginal bleeding 
  Preeclampsia or Eclampsia 
 Gestational hytertension 
 Other conditions where postoperative urine output monitoring is needed. 
 
 
 
All the participants enrolled in this study for elective cesarean section 
were screened for inclusion.  
For all participants informed consent is obtained written in the easier 
and eligible form. 
A total of 180 women were participated in the study group. They were 
divide into two groups by random allocation table.  
In Group I: catheter removal was done 18-24hours postoperatively in 
100 women. 
In Group II: Catheter removal was done immediately after the procedure 
in 80 women. 
Patient preparation: 
            All the women who were included in the study, preoperative urine 
microscopy were sent and UTI was ruled out. Any patient under the exclusion 
criteria were excluded from the study. 
              In all participants, clinical examination was performed. Non stress test 
was performed on the day of admission. Recently performed hematocrit and 
serology, blood Grouping and typing is checked. Informed consent for cesarean 
section and anesthesia are obtained. They kept NPO atleast 8 hours prior to 
surgery. Antibiotic prophylaxis of 1g cefazolin is given 30 minutes prior to 
surgery after the test dose.   
 
 
                In all women who were undergoing elective cesarean section, a foley 
catheter (French size 16) was inserted under sterile precautions on the 
operating table immediately before starting cesarean section. Person who 
catheterized the patient was noted. 
               Cesarean sections were performed in the usual manner under spinal 
anesthesia. Abdomen opened by pfannensteil incision. Then dissecting through 
different layers of abdomen until the uterus is reached. While in the past a 
vertical incision was commonly used, this was associated with scar rupture 
during future pregnancies, as a result lower segment transverse incisions is 
preferred nowadays and the baby delivered. Uterus is closed with vicryl. 
Abdomen closure was done. 
In all group II participants, catheter was removed immediately after 
surgery. 
Patients are shifted to postoperative care unit and monitored for 4hours. 
  Immediately after catheter removal, women were encouraged to void. 
As ambulation is impossible they were trained to void in the bedpan. After 18-
24hrs they were helped to ambulate and void in the bathroom. If even after 8 
hrs of removal, if they are not able to void or if there is palpable bladder, 
recatheterization is necessary.   
Urinary retention means – difficulty to void 8 hours after catheter 
removal or residual urine ≥200ml 
 
 
 OUTCOME MEASURES: 
1. Significant bacteriuria (clean catch midstream urine sample 
postoperatively after 48-72hours) 
2. 1st post operative voiding time (from the removal of catheter in hours) 
3. Postoperative Ambulation time  
4. Patient comfortness with catheter  categorized as  
1. comfort 
2. mild discomfort  
3. significant discomfort 
5. Other outcome measures measured are dysuria (defined as painful 
micturition); frequency (micturition more than 7 times during the day or 
more than twice during the night); urgency (severe irresistible urge to 
micturate). 
6.  Length of hospital stay – calculated from the day of surgery till 
discharge. 
        
Our hypothesis was that immediate catheter removal would be safe as 
delayed catheter removal after elective cesarean section and reduces the 
incidence of post UTI, improves patient comfort and helps early ambulation.  
 
 
RESULTS 
During the study period, a sum of 180 women finally enrolled in this 
trial. Out of which, in 80 of them catheter removed immediately and in 100 
women delayed catheter removal done. The two groups were matched and 
there were no significant differences between the two groups regarding 
maternal age, gestational age and parity. 
 
AGE DISTRIBUTION OF PATIENTS 
 
 
 
SAMPLES ARE MATCHED WITH   p = 0.469 
  
20 - 25 26 - 30 31 - 35 36 - 40
Group I 24% 50% 21% 5%
Group II 23% 53% 20% 5%
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PARITY 
 
PARITY Group I Group II 
 NO % NO % 
PRIMI 19 19 12 15 
MULTI 81 81 68 85 
TOTAL 100  80  
 
 
Totally 15.5% and 19%were primi mothers and 85% and 81% were multi 
respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VARIABLES Group I n=100 
Group II 
n=80 p-VALUE 
PARITY 2.27±0.9 2.35 ±0.96 0.5 
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GESTATIONAL AGE IN WEEKS 
 
 
 
GESTATIONAL AGE IN BOTH GROUPS WAS MATHCHED WITH 
p=0.11 
 
 
 
 
 
 
 
 
 
 
35 36 37 38 39
Group I 1% 0% 18% 68% 13%
Group II 0% 1% 30% 63% 6%
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INDICATION FOR CESAREAN SECTION 
 
 
 
In both the groups the common indication is previous cesarean section and 
there is no significant difference between them.  
 
 
 
Prev LSCS Breech Others
Group I 71% 15% 14%
Group II 80% 15% 5%
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PERSON CATHETERIZED 
 
 
 
In both the groups, most of the patients were catheterized by the 
postgraduate. 
  
PG CRRI AP/PROFFESOR
Group I 80% 20% 0%
Group II 70% 28% 3%
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URINARY RETENTION 
 
RECATHETERISATION GROUP I GROUP II Total 
NO 100 78 178 
YES 0 2 2 
Total 100 80 180 
 
 
2 women in immediate catheter removal group had urinary retention 
necessitating recatheterization. But none of the women in delayed catheter 
removal group were recatheterized.  
The p value is 0.196 
 
NO YES
Group I 100% 0%
Group II 98% 3%
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POSTOPERATIVE URINARY COMPLICATIONS 
DYSURIA: 
 
 
 
 
 
 
 
 
NO YES
Group I 96% 4%
Group II 98% 3%
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URINARY FREQUENCY: 
 
 
 
 
 
 
 
 
NO YES
Group I 88% 12%
Group II 95% 5%
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URGENCY: 
 
 
 
 
 
 
 
 
NO YES
Group I 97% 3%
Group II 99% 1%
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BURNING MICTURITION: 
 
Regarding urinary complications after catheter removal, burning 
micturition is lower in immediate catheter removal group.  
 
 
 
 
 
 
 
 
NO YES
Group I 75% 25%
Group II 93% 8%
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PATIENT COMFORTNESS WITH CATHETER: 
180 PATEINTS WERE REVIEWED ABOUT THE 
COMFORTNESS OF THE CATHETER. 
In group I: 15% had significant discomfort.33% had mild 
discomfort 
 In group II: Immediate removal group does not have any 
discomfortness 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIRST POSTOPERATIVE VOIDING TIME 
FIRST VOIDING 
TIME 
DELAYED 
REMOVAL 
 
n=100 
IMMEDIATE 
REMOVAL 
n=80 
Mean ±SD 13.4±1.3 4.8±1.1 
 
THE MEAN POSTOPERATIVE TIME TILL THE FIRST VOIDING IS 
STATISTICALLY SIGNIFICANT. 
The p value is < 0.001 
The first voiding time in immediate removal is shorter than delayed 
catheter removal patients. 
 
 
 
 
 
 
 
 
 
 
POSTOPERATIVE AMBULATION 
POSTOPERATIVE 
AMBULATION TIME 
GROUP I GROUP II 
MEAN±SD 29±2 17±4 
TOTAL 24 7 
 
The mean postoperative ambulation time lower in immediate catheter 
removal group than delayed catheter removal .It is statistically significant 
p=<0.001. 
 
 
 
 
 
 
 
 
 
 
 
 
DURATION OF HOSPITAL STAY 
HOSPITAL STAY Mean SD Sig 
GROUP I 5.7 0.9  
GROUP II 4.8 1.0 <0.001 
Total 5.3 1.0  
 
The p value =<0.001.The duration of hospital stay is significantly shorter 
in immediate catheter removal group.  
 
 
 
 
 
 
 
 
 
 
 
LEUKOCYTES: 
 LEUKOCYTE 
NEGATIVE 
LEUKOCYTE  
POSITIVE 
Group I 76(76%) 24(24%) 
Group II 72(90%) 8(10%) 
 
p value =< 0.01.The incidence of postoperative significant bacteriuria is 
statistically significant in immediate catheter removal groups. 
Leukocyte Positive groups were sent culture.  
 
URINE CULTURE: 
Urine culture showed growth of E.COLI in 6 women in delayed catheter 
removal group and in 1 woman in immediate catheter removal group. 
Other cultures were sterile. 
P Value = 0.03 
 
 
 
 
 
 
DISCUSSION 
              Cesarean section is the most common obstetric procedure in practice 
now with increasing rates .One of the prerequisite for cesarean delivery is the 
insertion of a urethral catheter before surgery. The catheter is placed to 
facilitate surgery by blunt dissection of underlying bladder.  
             It is a usual practice to leave the catheter for 24-48hours after the 
cesarean section. One of the complications of urethral catheter in cesarean 
section is CAUTI (catheter associated urinary tract infections). 
CAUTI:  
               A catheter associated urinary infection is one of the most common 
infections a person can contract in the hospital. Catheter – related urinary tract 
infection are common because urethral catheters inoculate organisms into the 
bladder and promote colonization for bacterial adhesion and causing mucosal 
irritation. 
              Once a catheter is placed, the daily incidence of bacteriuria is 3-
10%.Between 10% and 30% of patients who undergo short term catheterization 
(i.e. 2-4days) develop bacteriuria and are asymptomatic. Between 90% and 
100% of patients who undergo long term catheterization develop bacteriuria  
About 80% of nosocomial UTIs are related to urethral catheterization; 
only 5-10% is related to genitourinary manipulation. 
 
 
      The bacteria may gain entry into the bladder during insertion of the 
catheter, during manipulation of the catheter or drainage system. 
Risk factors for bacteriuria in patients who are catheterized: 
1. Longer duration of catheterization 
2. Colonization of the drainage bag 
3. Absence of antibiotics  
4. Female gender 
5. Renal insufficiency 
6. Improper catheter care 
The 2009 centers for Disease Control and Prevention(CDC) guidelines 
for the prevention of catheter – associated urinary tract infections 
recommends catheter use only for appropriate indications. 
                   Catheter use and duration should be minimized in all patients, 
especially those at higher risk for CAUTI (e.g. elderly persons, woman and 
patients with impaired immunity.  
Urinary catheters coated with silver alloy also reduce the risk of infection.73 
 
UTI IN PREGNANCY: 
                    Urinary tract infections are more common in women and in 
pregnancy. The female anatomy makes it easy for bacteria from the vagina or 
rectal areas to get in the urinary tract because they are close together. 
 
 
      UTIs are common during pregnancy. That’s because the growing fetus can 
put pressure on the bladder or causes urine to leak. There are also physical 
changes to consider. As early as six weeks gestation, almost all the pregnant 
women experience ureteral dilation, when the urethra expands and continues to 
expand until delivery. 
   The larger urinary tract, along with increased bladder volume and 
decreased bladder tone, all cause the urine to become more still in the urethra. 
This allows bacteria to grow. Pregnant woman’s urine gets more concentrated. 
It also has certain types of hormones and sugar. These encourage bacterial 
growth and lower your body’s ability to fight off bacteria. 
Between 2-10% of pregnant women pregnant women experience a UTI. 
Women who have UTIs before are more prone to get them during pregnancy. 
The same goes for women who have had several children (multiparous). 
 
 
  
 
 
                  Recent studies have refuted the use of urethral catheter for longer 
duration, especially in women undergoing elective cesarean delivery. 
This study is undertaken to determine whether immediate catheter 
removal decreases the occurrence of urinary tract infection, shortens first 
postoperative voiding, ambulation time, duration of hospital stay and the need 
for recatheterization for urinary retention. 
In this study, women admitted in the ward elective cesarean section 
were selected after screening for eligibility. 
Totally 180 women participated in the study and in all participants. 
Foley catheter of is inserted immediately in all the women. 
In Group I: In 100 women catheter removal was done 18-24hours 
postoperatively. 
In Group II: In 80 women catheter removal was done immediately. 
           In Group I and II, we compared the Age, Parity, Gestational age; 
Indication for cesarean section, Person catheterized the patient. 
Postoperatively:  Recatheterization, dysuria, urgency, frequency, burning 
micturition, Patient comfortness, and significant bacteriuria.  
 First voiding time, Postoperative ambulation time, Duration of hospital 
stay were compared postoperatively. 
 
 
 
 
      In the present study, we compared the age group, parity and gestational age 
between the two groups and they were matched and there is no significant 
difference. 
If we compare the age distribution of patients in both the groups, 50-
55% of them are between 26-30 years of age. 
      Comparing the parity 15% -20% are primi and 80-85% are multi in both the 
groups. 
        In both the groups, the gestational age of women in which elective 
cesarean section undergone  is between 37-39 weeks.60% -70% of them are 
mostly 38 weeks. 20-30% is 37weeks.6-12% belongs to 39 weeks. 
       In both group I and II, the indication for elective cesarean section is 
because due to previous cesarean section which is of 70-80%.15% are done 
because of Breech presentation. Others like placenta previa, transverse lie are 
only 5-15%. 
      Similarly Anand Nikhil 74 analyzed the indications for elective and 
emergency cesarean in modern day practice, a study conducted GMERS 
medical collage sola, Ahmadabad, carried out over a period between June 2013 
to December 2013.He concluded that frequency of LSCS was 25.1% during the 
study period and indications of LSCS in the order of frequency is a previous 
LSCS (42.09%).   
 
 
                           
     In this study when we compare the person who catheterized, in both the 
groups 80% of the women are catheterized by postgraduate and 20-30% by 
Interns. 
       Comparing the urinary retention between the immediate and delayed 
catheter removal groups, only 2 of them in the immediate catheter removal 
group didn’t void till 8 hours, so needed recatheterization. 
None of them in the delayed catheter removal group needed catheterization. 
          Similar results shown by Divya Pandey and his colleagues75 involves 150 
participants, 75 are assigned to each group. Group I: were non-catheterized and 
Group II – catheterized for 24 hours postoperatively.  
Postoperative retention is seen in one patient of non – catheterized group 
but statistically not significant (p=0.285).  
     We compared the postoperative urinary complications in Group I and Group 
II, dysuria, frequency and urgency, the incidence is lower in immediate catheter 
removal group but statistically not significant. 
25% positive in Group I 
8% positive in Group II 
Burning micturition is statistically significant p =<0.01. 
 
 
      Similar results shown by Akmal El – Mazny, a study conducted in 
Cairo University, in which 300 women were allocated into two groups. 
Regarding urinary complications, it is significantly lower in immediate catheter 
removal group.30   
       All the180 participants on the first postoperative day were reviewed about 
the comfort of the catheter. In group I, 15% had significant discomfort and 
33% had mild discomfort. 
In group II, immediate catheter removal group none of them had 
discomfort. This helps in earlier ambulation.   
     A M Nasr and his colleague 45conducted a study in which 420 gravid 
women undergoing cesarean were prospectively included and randomized into 
two groups. Group 1 - uncatheterized and group 2 – catheter removal done after 
12hrs postoperatively 
  The level of pain and discomfort was recorded categorically using 
McGill Pain Questionnaire. There was a statistically significant association 
between the degree of discomfort and the use of indwelling catheter (p<0.001)  
        Postoperative voiding time is the first time voiding after catheter removal. 
Duration is from insertion of catheter to the first voiding time after catheter 
removal. The p value is statistically significant <0.001. 
      Comparing the ambulation time between immediate and delayed catheter 
removal group, the time shortens in Group II. P value = <0.001. 
 
 
Group I: Mean 29±2hrs 
Group II: Mean 17±4 
Duration of hospital stay is shorter in immediate catheter removal group. 
p value = <0.001. 
Ghoreishi conducted a randomized controlled study, in which 270 
women are participated. Compared the ambulation time in UC 6.8H, vs. 12.9H 
in the control group. 
Ghoreishi concluded that uncatheterized have less ambulation time and 
hospital stay.    
         Similarly by Nasr et al45 concluded in his ambulation time was 7.7 ±3.42 
hours in uncatheterized and 13.4±9.9 in catheterized group. 
        Comparing the Leukocytes in Group I and II, Group I had 24% positive 
and 8% positive in immediate catheter removal group. p value <0.01. 
        Urine culture showed E.coli growth in 6 women in delayed catheter 
removal group and in 1 woman in immediate catheter removal group. 
      Onile et al compared early versus delayed catheters for elective cesarean 
delivery. There was a non – significant, positive urine culture in early removal 
group. p=0.489. 
 
 
 
      Acharya S et al. conducted a study in Koirala institute, in which 150 
patients participated in the study.75 patients were catheterized and 75 of them 
are not catheterized. Urine routine was done on 1st postoperative day and urine 
culture was sent on second day. He concluded that positive urine analysis for 
urinary tract infection was high in catheterized group (p<0.001).E.coli was 
isolated in 12.7% in catheterized group. 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 In this study, 180 antenatal women consented for the study had an 
indication for elective cesarean section. In 80 women the catheter were 
removed immediately after the cesarean section and in 100 of them 
catheter removed 18-24hours later as in usual manner.  
 The most common indications for cesarean is found to be because of 
previous cesarean section (80%) and Breech presentation (15%) 
 In our study most of the catheterization was done by postgraduates.(80% 
of PGs in delayed removal and 70%  of them in early removal group) 
 In conclusion, immediate removal of catheter lowers the incidence of 
UTI compared with delayed catheter removal. Only 8% had significant 
bacteriuria compared with control group which is 24% 
 Patient feels comfort and urinary complications like dysuria, urgency, 
frequency, burning micturition lowers with immediate removal of 
catheter. 
 In delayed catheter removal group 33% had mild discomfort and 15% 
had significant discomfort reviewed on the day of surgery. Patient’s 
satisfaction was assessed among both the groups and immediate removal 
helps them in breastfeeding the baby easier and helps in ambulation 
faster.  
 Their first voiding time and ambulation time shortens compared to 
control group.  
 
 
  There is also need of 3% recatheterization in immediate removal group 
though in delayed removal no one recatheterized. 
 It is difficult to state that immediate removal group could cause 
complication of postpartum hemorrhage because no information is 
provided on the catheterized group. 
                    Moreover hemorrhage might result from several causes so it is 
difficult to confirm it. 
 The duration of hospital stay also decreases with immediate catheter 
removal. 
 Compared with routine catheterization, the  non- placement or 
immediate catheter removal is associated with a reduced incidence of 
UTIs, less discomfort, first voiding time, ambulation, shorter hospital 
stay. 
 
Hereby we conclude that immediate postoperative removal of catheter 
after elective cesarean section is recommended, unless another indication 
necessitating prolonged catheterization.  
 
 
STATISTICAL ANALYSIS 
 
Descriptive and inferential statistical analysis is carried out in this study 
.Results on continuous measurements are represented as Mean +/- SD (min – 
max) and results on categorical measurements are represented as numbers 
(%).Significance between both the groups are assessed at 5% significance 
level. The following data assumptions are made: 1.Dependent variables are 
normally distributed among both the groups.2.Samples drawn from the 
population is random; cases of the samples are independent. 
                       Student t test (independent, two tailed) was used to find the 
significance of the parameters in the study on a continuous scale between both 
the groups (inter group analysis) on metric parameters. Fisher exact test/ chi 
square test were used to find the significance among the parameters in this 
study on categorical scale between both the groups. 
Significant figures: 
+ Suggestive significance (p value: 0.05<p<0.01) 
*Moderately significant (p value: 0.01<p<0.05) 
**Strongly significant (p value: p<0.01) 
Statistical software: The statistical software namely SPSS was used for the 
data analysis and Microsoft excel was used to generate tables, graphs and 
charts. 
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PROFORMA 
NAME: 
AGE: 
SNO: 
OP NO: 
IP NO: 
ADDRESS: 
UNIT: 
SOCIOECONOMIC  STATUS: 
MENSTRUAL  HISTORY: 
OBSTETRIC HISTORY: 
O/E: 
PR: 
BP: 
TEMP: 
PALLOR: 
ICTERUS: 
CVS: 
RS: 
P/A: UTERUS HEIGHT: 
       PRESENTING PART: 
       FETAL HEART : 
ANTENATAL   COMPLICATION : 
INDICATION FOR CESAREAN SECTION: 
 
 
PRE –OP URINE  ROUTINE : ( 1 DAY PRIOR TO SURGERY) 
PRE – OP HEMOGLOBIN : 
DATE AND TIME OF CESAREAN SECTION: 
TYPE OF ANAESTHESIA: 
PERSON WHO CATHETERIZED: 
INTRA OP FINDINDS: 
TIME OF CATHETER REMOVAL: 
GROUP A : IMMEDIATE  FOLEYS CATHETER REMOVAL: 
GROUP B : DELAYED  FOLEYS CATHETER  REMOVAL (18-24 
HRS):  
MEAN TIME TO PATIENT AMBULATION : 
TIME OF FIRST POST OP VOIDING : 
RECATHERISATION DONE /NOT: 
PATIENTS COMFORT/DISCOMFORT DUE TO CATHETER: 
COMFORTABLE/MILD DISCOMFORT/SIGNIFICANT 
DISCOMFORT: 
DYSURIA: 
URINARY FREQUENCY AND URGENCY: 
BURNING MICTURITION: 
POST-OP URINE ROUTINE (48-72 HOURS): 
URINE CULTURE: 
DURATION OF HOSPITAL STAY: 
 
 
 
 
 
PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT FORMAT FOR RESEARCH PROJECTS 
 
 
 
 
I   ____ Dr. VIJAYA HARINI.V___, am are carrying out a study on the topic : 
 
 A PROSPECTIVE STUDY OF COMPARING IMMEDIATE VERSUS DELAYED REMOVAL 
OF URINARY CATHETER FOLLOWING ELECTIVE CESAREAN SECTION 
as part of my / our research project being carried out under the aegis of the Department of: 
OBSTETRICS AND GYNAECOLOGY, PSG IMSR   
 
 My research guide is : Dr. SEETHA PANICKER MD.,DGO.,DNB 
 
The justification for this study is:  
                Elective cesarean is nowadays commonly performed with indwelling catheter mainly 
to decompress  the bladder and to avoid injury. This study is mainly performed  that immediate 
removal of catheter have various benefits from that of delayed removal.  
 
 
 
 
 
The objectives of this study are:  
 
Primary Objective: TO COMPARE THE OUTCOMES OF IMMEDIATE AND 18-24 HOURS 
REMOVAL OF URINARY CATHETER FOLLOWING ELECTIVE CESAREAN SECTION. 
 
Secondary Objective: 1) TO IMPLEMENT IMMEDIATE CATHETER REMOVAL AS AN 
EFFECTIVE AND SAFE METHOD 
2)TO  DECREASE URINARY TRACT INFECTION 
3)TO DECREASE THE DURATION OF HOSPITAL STAY 
CONSENT FOR RECATHETERIZATION: IF THE PATIENT REPORTS URGE TO VOID WHEN 
MOBILISATION WAS IMPOSSIBLE A  BADPAN WILL BE GIVEN.IF THE PATIENT HAD 
DIFFICULTY  IN PASSING URINE AFTER 6 HOURS AND /OR IF ABDOMINAL EXAMINATION 
SHOWS PALPABLE URINARY BLADDER,RECATHETERIZATION WILL BE NEEDED. 
 
 
Sample size: _____200___________  
 
Study volunteers / participants are (specify population group & age group): Women admitted to 
the prenatal wards for primary or repeat cesarean section  
 
Location: __PSG HOSPITAL ANTENATAL WARD ___.  
 
We request you to kindly cooperate with us in this study. We propose collect background 
information and other relevant details related to this study. We will be carrying out:  
 
Initial interview (specify approximate duration):___10_____ minutes.  
 
 
 
Data collected will be stored for a period of fifteen years. We will / will not use the data as part of 
another study. 
 
  
 
 Final interview for 10 mts. If photograph is taken, purpose: no 
 
Benefits from this study: DIRECT BENEFIT (To reduce urinary tract infection) 
 
Risks involved by participating in this study: No major risks 
 
How the results will be used: Can show positive correlation or negative correlation 
 
If you are uncomfortable in answering any of our questions during the course of the interview or 
discomfort in removing catheter immediately or 18-24 hours, you have the right to withdraw from 
the interview / study at anytime. You have the freedom to withdraw from the study at any point of 
time. Kindly be assured that your refusal to participate or withdrawal at any stage, if you so decide, 
will not result in any form of compromise or discrimination in the services offered nor would it attract 
any penalty. You will continue to have access to the regular services offered to a patient. You will 
NOT be paid any remuneration for the time you spend with us for this interview / study. The 
information provided by you will be kept in strict confidence. Under no circumstances shall we 
reveal the identity of the respondent or their families to anyone. The information that we collect 
shall be used for approved research purposes only. You will be informed about any significant new 
findings - including adverse events, if any, – whether directly related to you or to other participants 
of this study, developed during the course of this research which may relate to your willingness to 
continue participation. 
 
Consent: The above information regarding the study, has been read by me/ read to me, and has 
been explained to me by the investigator/s. Having understood the same, I hereby give my consent 
to them to interview me. I am affixing my signature / left thumb impression to indicate my consent 
and willingness to participate in this study (i.e., willingly abide by the project requirements).  
 
Signature / Left thumb impression of the Study Volunteer / Legal Representative:  
 
 
 
Signature of the Interviewer with date:      Witness: 
 
Contact number of PI: 7708559699 
 
Contact number of Ethics Committee Office:  0422 2570170 Extn.: 5818 
 
 
NO AGE GA G P L A ANT.COMP INDCS PREUR PERSCAT CATIN CATOUT 1STVOID AMB RECAT PTCOMF DYSURIA URGENCY FREQUEN BURNMIC POSTWBC POSTLEUC NITRITES CULTURE HOSPSTAY
1 32 38+4 3 1 1 1 PREV.LSCS 1 2 1 12PM 1HR 6HRS 17HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
2 28 37+2 4 1 1 2 PREV.LSCS 1 2 1 9AM 1HR 7HRS 20HRS 0 0 0 0 0 0 2 0 0 0 5DAYS
3 29 37+4 2 1 1 0 GDM 1 1 1 11.40AM 11/2HRS 0 28HRS 1 0 1 0 0 1 8 1 0 STERILE 7DAYS
4 26 38+2 4 1 1 2 HYPOTHYROID 1 1 1 11.40AM 1HR 3HRS 18HRS 0 0 0 0 0 0 1 0 0 0 5DAYS
5 34 38+3 3 1 1 1 PREV.LSCS 1 1 2 11.00AM 11/2HRS 5 1/2HRS 17HRS 0 0 0 0 0 1 8 1 0 STERILE 6DAYS
6 38 38+3 2 1 1 0 GDM 1 3 2 11.30AM 1HR 5 1/2HRS 19HRS 0 0 0 0 0 0 7 TRACE 0 0 6DAYS
7 27 38+0 3 1 1 0 PREV.LSCS 1 3 1 9.00AM 1HR 6HRS 20HRS 0 0 0 0 0 0 2 0 0 0 6DAYS
8 31 38+1 5 1 1 3 PREV.LSCS 1 4 1 9.30AM 1HR 7hrs 22hrs 0 0 0 0 0 0 9 0 0 0 5DAYS
9 20 38+0 2 1 1 0 GDM 1 3 2 1.00PM 1HR 6HRS 17HRS 0 0 0 0 1 1 22 2 0 STERILE 6DAYS
10 28 38+6 3 1 1 1 PREV.LSCS 1 2 1 11.30AM 1HR 4HRS 18HRS 0 0 0 0 0 0 1 0 0 0 4DAYS
11 21 39+2 1 0 0 0 GDM 1 0 1 10.00AM 1HR 6HRS 22HRS 0 0 1 0 1 1 38 1 0 STERILE 6DAYS
12 30 38+5 3 1 1 1 PREV.LSCS 1 1 2 1.00PM 1HR 5HRS 161/2HRS 0 0 0 0 0 0 1 0 0 0 5DAYS
13 30 38+2 2 1 1 0 PREV.LSCS 1 2 2 9.00AM 1HR 5HRS 20HRS 0 0 0 0 0 0 2 0 0 0 5DAYS
14 35 37+6 2 1 1 0 HYPOTHYROID 1 1 2 9.00AM 11/2HRS 61/2HRS 20HRS 0 0 0 0 0 0 2 0 0 0 4DAYS
15 21 38+2 2 1 1 0 PREV.LSCS 1 1 1 11.30AM 1HR 6HRS 12HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
16 25 37+2 3 1 1 1 PREV.LSCS 1 1 1 9.00AM 11/2HRS 61/2HRS 19HRS 0 0 0 0 0 0 7 0 0 0 4DAYS
17 40 38+5 2 1 1 0 PREV.LSCS 1 2 1 8.00AM 1HR 5HRS 19HRS 0 0 0 0 0 0 2 0 0 0 5DAYS
18 26 37+6 2 1 1 0 ANEMIA 1 1 1 9.00AM 11/2HRS 71/2HRS 14HRS 0 0 0 0 0 0 5 0 0 0 5DAYS
19 23 38+0 3 1 1 1 RH NEGTIVE 1 1 1 11.00AM 1HR 10HRS 16HRS 0 0 0 0 0 0 7 0 0 0 4DAYS
20 25 38+1 2 1 1 0 PREV.LSCS 1 1 1 11.00AM 1HR 7HRS 17HRS 0 0 0 0 0 0 9 0 0 0 5DAYS
21 28 38+1 2 1 1 0 BREECH 2 1 1 12.00PM 1HR 7HRS 10HRS 0 0 0 0 0 0 6 0 0 0 6DAYS
22 25 38+2 2 1 1 0 PREV.LSCS 1 2 1 9.30AM 1HR 5HRS 15HRS 0 0 0 0 1 1 35 2 0 ECOLI 7DAYS
23 26 38+0 2 1 1 0 PREV.LSCS 1 2 1 10.30AM 1HR 7RHS 15HRS 0 0 0 0 0 0 0 0 0 0 5DAYS
24 25 37+0 3 2 2 0 PREV.LSCS 1 1 1 12.00PM 1HR 7HRS 16HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
25 25 38+5 2 1 1 0 PREV.LSCS 1 1 1 11.00AM 11/2HRS 6HRS 14HRS 0 0 0 0 0 0 7 0 0 0 5DAYS
26 25 38+2 2 1 1 0 ANEMIA 1 2 1 1.00pm 1HR 7hrs 16hrs 0 0 0 0 0 0 7 0 0 0 6DAYS
27 27 38+3 2 1 1 0 GDM 1 1 1 1.00pm 1HR 5hrs 14hrs 0 0 0 0 0 0 8 0 0 0 4DAYS
28 27 37+2 2 1 1 0 GDM 1 4 1 12.00pm 1HR 4hrs 20hrs 0 0 0 0 0 0 2 0 0 0 5DAYS
29 30 37+5 5 1 1 3 PREV.LSCS 1 2 1 1.00pm 1HR 6hrs 12hrs 0 0 0 0 0 0 0 0 0 0 4DAYS
30 24 38+1 3 1 1 1 PREV.LSCS 1 6 1 10.30am 11/2HRS 6hrs 10hrs 0 0 0 0 0 0 6 0 0 0 5DAYS
31 34 37+0 2 1 1 0 BREECH 2 4 2 9.00AM 11/2HRS 7HRS 13HRS 0 0 0 0 0 0 5 0 0 0 6DAYS
32 27 38+0 1 0 0 0 TWIN 1 0 3 10.30AM 1HR 6HRS 12HRS 0 0 0 0 0 0 6 0 0 0 5DAYS
33 26 37+4 3 2 2 0 PREV.LSCS 1 5 1 9.00AM 1HR 6HRS 24HRS 0 0 0 0 0 0 8 0 0 0 6DAYS
34 31 37+0 2 1 1 0 BREECH 2 6 2 10.30AM 1HR 6HRS 18HRS 0 0 0 0 0 0 1 0 0 0 5DAYS
35 34 38+0 4 1 1 2 BOH 1 7 1 9.00AM 11/2HRS 0 27HRS 1 0 0 0 0 0 1 0 0 0 7DAYS
36 29 37+5 2 1 1 0 BREECH 2 1 1 12.00PM 1HR 5HRS 15HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
37 29 38+6 2 1 1 0 PREV.LSCS 1 6 1 11.00AM 11/2HRS 7HRS 17HRS 0 0 0 0 0 0 10 0 0 0 4DAYS
38 27 38+5 2 1 1 0 PREV.LSCS 1 6 1 10.00AM 1HR 6HRS 19HRS 0 0 0 0 0 0 8 0 0 0 6DAYS
39 29 38+2 2 1 1 0 PREV.LSCS 1 6 1 11.00AM 1HR 7HRS 18HRS 0 0 0 0 0 0 6 0 0 0 5DAYS
40 37 38+0 2 1 1 0 PREV.LSCS 1 2 2 9.00AM 11/2HRS 5HRS 14HRS 0 0 0 0 0 0 0 0 0 0 4DAYS
 
 
 
 
 
 
 
 
 
 
 
 
 
41 25 37+2 2 1 1 0 HYPOTHYROID 1 0 1 12.30PM 11/2HRS 6HRS 16HRS 0 0 0 0 0 0 6 0 0 0 6DAYS
42 27 38+2 3 1 1 1 ANEMIA 1 1 2 11.00AM 1HR 7HRS 18HRS 0 0 0 0 0 0 6 0 0 0 4DAYS
43 27 37+4 2 1 1 0 PREV.LSCS 1 1 1 10.00AM 1HR 5HRS 20HRS 0 0 0 0 0 0 6 TRACE 0 0 5DAYS
44 28 38+1 3 1 1 0 GDM 1 2 2 9.30AM 11/2HRS 6HRS 20HRS 0 0 0 0 0 0 2 TRACE 0 0 4DAYS
45 27 38+1 2 1 1 0 PREV.LSCS 1 3 1 11.30AM 1HR 4HRS 19HRS 0 0 0 0 0 0 4 0 0 0 5DAYS
46 25 37+ 3 1 1 1 HYPOTHYROID 1 1 2 10.00AM 11/2HRS 5HRS 17HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
47 28 38+2 2 1 1 0 GDM 1 2 1 10.00AM 11/2HRS 7HRS 19HRS 0 0 0 0 0 0 3 0 0 0 5DAYS
48 27 38+5 2 1 1 0 PREV.LSCS 1 6 1 1.00pm 1hr 7hrs 16hrs 0 0 0 0 0 0 8 0 0 0 6DAYS
49 25 38+3 1 0 0 0 BREECH 2 8 1 9.00AM 1HR 7HRS 13HRS 0 0 0 0 0 0 4 0 0 0 5DAYS
50 27 39+0 1 0 0 0 TWIN 3 1 2 8.00AM 1HR 5HRS 10HRS 0 0 0 0 0 0 7 0 0 0 6DAYS
51 29 38+0 1 0 0 0 OLIGOHYDRAM 2 1 1 10.00AM 11/2HRS 7HRS 19HRS 0 0 0 0 0 0 3 0 0 0 5DAYS
52 28 39+0 2 1 1 0 PREV.LSCS 1 0 2 12.00PM 1HR 1HR 12HRS 0 0 0 0 1 0 10 0 0 0 3DAYS
53 35 38+2 2 1 1 0 PREV.LSCS 1 5 2 10.30AM 1HR 6HRS 12HRS 0 0 0 0 0 0 7 0 0 0 5DAYS
54 24 38+6 2 1 1 0 PREV.LSCS 1 7 1 10.30AM 1HR 6HRS 18HRS 0 0 0 1 0 0 4 0 0 0 5DAYS
55 34 37+3 4 1 1 2 IUGR 1 1 2 8.00AM 11/2HRS 7HRS 17HRS 0 0 0 0 0 0 7 0 0 0 3DAYS
56 26 37+4 3 2 2 0 PREV.LSCS 1 5 1 9.00AM 1HR 6HRS 24HRS 0 0 0 0 0 0 6 0 0 0 4DAYS
57 31 37+0 2 1 1 0 BREECH 2 3 1 11.00AM 1HR 7HRS 18HRS 0 0 0 0 0 0 1 0 0 0 4DAYS
58 35 37+6 1 0 0 0 TRANSVERSELIE 3 2 1 8.30AM 1HR 6HRS 17HRS 0 0 0 0 0 0 10 TRACE 0 0 5DAYS
59 26 38+4 2 1 1 0 PREV.LSCS 1 3 1 10.30am 11/2HRS 7hrs 18HRS 0 0 0 0 0 0 0 0 0 0 3DAYS
60 29 38+2 4 1 1 2 ANEMIA 1 5 1 11.00AM 1HR 6HRS 19HRS 0 0 0 0 0 0 6 0 0 0 4DAYS
61 27 38+5 2 1 1 0 PREV.LSCS 1 2 1 10.00AM 1HR 7HRS 15HRS 0 0 0 0 0 0 4 0 0 0 4DAYS
62 28 38+4 3 1 1 1 PREV.LSCS 1 1 1 12.00PM 11/2HRS 8HRS 24HRS 0 0 0 0 0 0 6 0 0 0 5DAYS
63 28 37+5 4 1 1 2 IUGR 2 1 1 8.00AM 1HR 7HRS 10HRS 0 0 0 0 0 0 11 TRACE 0 STERILE 6DAYS
64 29 37+4 2 1 1 0 PREV.LSCS 1 1 1 9.00AM 1HR 6HRS 13HRS 0 0 0 0 0 0 5 0 0 0 4DAYS
65 25 38+3 1 0 0 0 BREECH 2 1 2 1.00PM 11/2HRS 7HRS 10HRS 0 0 0 0 0 0 0 0 0 0 4DAYS
66 24 38+1 2 1 1 0 PREV.LSCS 1 3 2 10.30AM 11/2HRS 7HRS 18HRS 0 0 0 0 0 0 5 0 0 0 4DAYS
67 27 38+5 2 1 1 0 PREV.LSCS 1 0 2 12.00PM 1HR 5HRS 13HRS 0 0 0 0 0 0 1 0 0 0 3DAYS
68 29 37+4 1 0 0 0 HYPOTHYROID 3 6 1 10.00AM 1HR 6HRS 16HRS 0 0 0 0 0 0 7 0 0 0 4DAYS
69 28 38+3 5 1 1 3 BOH 1 4 1 8.00AM 11/2HRS 61/2HRS 14HRS 0 0 0 0 0 0 2 0 0 0 4DAYS
70 27 39+0 1 0 0 3 BREECH 2 3 1 2.00pm 1HR 5HRS 10HRS 0 0 0 0 0 0 8 0 0 0 5DAYS
71 29 38+0 2 1 0 0 PREV.LSCS 1 4 2 9.00AM 1HR 6HRS 12HRS 0 0 0 0 0 0 0 0 0 0 4DAYS
72 28 37+4 4 1 1 2 PREV.LSCS 1 2 3 10.00AM 1HR 7HRS 16HRS 0 0 0 0 0 1 6 0 0 0 5DAYS
73 30 38+0 1 0 0 0 OLIGOHYDRAM 2 1 1 10.00AM 11/2HRS 7HRS 19HRS 0 0 0 0 0 0 5 0 0 0 4DAYS
74 35 38+2 2 1 1 0 PREV.LSCS 1 5 1 3.00PM 1HR 5HRS 14HRS 0 0 0 0 0 0 1 0 0 0 3DAYS
75 25 39+0 1 0 0 0 BREECH 2 0 0 8.00AM 1HR 51/2HRS 16HRS 0 0 0 0 0 0 2 0 0 0 5DAYS
76 31 37+0 2 1 1 0 PREV.LSCS 1 3 2 11.00AM 1HR 7HRS 18HRS 0 0 0 0 0 0 5 0 0 0 4DAYS
77 38 38+3 3 1 1 1 PREV.LSCS 1 0 2 11.30AM 1HR 71/2HRS 18HRS 0 1 0 0 0 0 7 0 0 0 3DAYS
78 32 36+6 2 1 1 0 IUGR 1 5 1 8.00AM 1hr 6HRS 12HRS 0 0 0 0 0 0 0 0 0 0 5DAYS
79 35 38+6 3 1 1 1 ANEMIA 1 2 1 9.00AM 1HR 6HRS 15HRS 0 0 0 0 0 0 5 0 0 0 3DAYS
80 32 38+4 1 0 0 0 TRANSVERSELIE 3 5 1 10.30AM 11/2HRS 6HRS 16HRS 0 0 0 0 0 0 1 0 0 0 5DAYS
 
 
 
 
 
 
 
 
 
 
 
 
 
NO AGE GA G P L A ANT.COMP INDCS PREUR PERSCAT CATIN CATOUT 1STVOID AMB RECAT PTCOMF DYSURIA URGENCY FREQUEN BURNMIC POSTWBC POSTLEUC NITRITES CULTURE HOSPSTAY
1 36 38+1 3 1 1 1 PREVLSCS 1 2 1 9.00AM 24HRS 2HRS 30HRS 0 2 0 0 0 0 1 0 0 0 5DAYS
2 29 38+2 3 1 1 1 GDM 1 1 1 12.OOPM 21HRS 4HRS 28HRS 0 1 0 0 0 0 7 0 0 0 6DAYS
3 25 38+1 4 1 1 2 PREVLSCS 1 2 1 9.00AM 24HRS 3HRS 31HRS 0 3 0 0 0 0 4 TRACE 0 0 5DAYS
4 26 38+2 3 1 1 1 PREVLSCS 1 2 1 11.00AM 22HRS 2HRS 26HRS 0 2 0 0 0 1 1 0 0 0 5DAYS
5 26 38+4 3 1 1 1 PREVLSCS 1 1 1 3.30PM 19HRS 1HR 23HRS 0 1 0 0 0 0 1 0 0 0 5DAYS
6 28 37+5 3 1 1 1 ANEMIA 1 2 1 10.00AM 23HRS 2HRS 28HRS 0 3 0 0 1 1 11 1 0 STERILE 7DAYS
7 30 38+5 3 2 1 0 PREVLSCS 1 2 2 9.30AM 23HRS 3HRS 31HRS 0 2 0 0 0 0 1 0 0 0 5DAYS
8 23 38+4 2 1 1 0 PREVLSCS 1 2 1 9.30AM 231/2HRS 3HRS 30HRS 0 2 0 0 0 1 4 0 0 0 6DAYS
9 35 38+3 2 1 1 0 PREVLSCS 1 2 1 11.00AM 22HRS 2HRS 28HRS 0 3 1 0 1 1 29 3 0 ECOLI 8DAYS
10 32 38+0 2 1 1 0 HYPOTHYROID 1 2 1 9.30AM 23HRS 4HRS 33HRS 0 2 0 0 0 0 2 0 0 0 5DAYS
11 26 38+2 4 1 1 2 PREVLSCS 1 2 1 11.00AM 22HRS 4HRS 28HRS 0 3 0 0 1 1 28 3 0 ECOLI 7DAYS
12 27 38+4 3 1 1 1 PREVLSCS 1 1 2 9.30AM 23HRS 3HRS 32HRS 0 3 0 0 0 0 4 0 0 0 5DAYS
13 28 38+0 2 1 1 0 HYPOTHYROID 1 2 1 10.00AM 23HRS 5HRS 31HRS 0 1 0 0 0 0 8 0 0 0 5DAYS
14 28 39+0 1 0 0 0 BREECH 2 1 2 2.00PM 19HRS 4HRS 25HRS 0 3 0 0 0 0 3 0 0 0 5DAYS
15 36 38+6 2 1 1 0 PREVLSCS 1 2 1 10.00AM 23HRS 4HRS 31HRS 0 2 0 0 0 0 8 0 0 0 5DAYS
16 29 38+2 2 1 1 0 PLAC.PREVIA 3 2 1 11.00AM 22HRS 4HRS 30HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
17 36 37+0 2 1 1 0 PREVLSCS 1 2 1 11.00AM 24HRS 2HRS 28HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
18 32 38+0 4 1 1 2 GDM 1 1 2 12.00PM 21HRS 2HRS 25HRS 0 2 0 0 0 0 1 0 0 0 6DAYS
19 26 38+4 2 1 1 0 PREVLSCS 1 1 1 10.00AM 22HRS 4HRS 29HRS 0 1 0 0 0 0 4 0 0 0 5DAYS
20 28 39+2 1 0 0 0 BREECH 2 1 1 9.00AM 24HRS 6HRS 32HRS 0 1 0 0 0 0 8 0 0 0 5DAYS
21 26 37+0 4 1 1 2 IUGR 1 1 2 8.00AM 24HRS 1HR 31HRS 0 2 0 0 0 1 2 0 0 0 5DAYS
22 26 38+0 1 0 0 0 MYOMECTOMY 3 6 1 2.00PM 19HRS 3HRS 24HRS 0 1 0 0 0 0 8 0 0 0 5DAYS
23 22 39+4 2 1 1 0 BREECH 2 4 1 10.00AM 23HRS 7HRS 30HRS 0 2 1 0 0 1 8 TRACE 0 0 6DAYS
24 22 38+0 2 1 1 0 PREVLSCS 1 1 1 9.00AM 23HRS 3HRS 30HRS 0 2 0 0 1 1 12 TRACE 0 STERILE 5DAYS
25 35 37+0 3 1 1 1 IUGR 1 2 1 11.00AM 22HRS 5HRS 28HRS 0 1 0 0 0 0 5 0 0 0 7DAYS
26 31 38+0 2 1 1 0 PREVLSCS 1 5 1 12.00PM 21HRS 3HRS 29HRS 0 3 1 1 0 1 20 3+ 0 ECOLI 6DAYS
27 23 39+0 1 0 0 0 TRANS.LIE 3 1 1 1.00PM 19HRS 4HRS 30HRS 0 1 0 0 0 0 0 0 0 0 6DAYS
28 35 38+5 1 0 0 0 BREECH 2 2 1 11.30AM 23HRS 3HRS 30HRS 0 3 0 0 0 0 1 0 0 0 5DAYS
29 35 35+3 1 0 0 0 TRANS.LIE 3 2 1 10.00AM 20HRS 6HRS 31HRS 0 3 1 0 0 1 15 1 0 STERILE 6DAYS
30 32 37+1 3 2 2 0 IUGR 1 6 1 11.00AM 20HRS 6HRS 26HRS 0 1 0 0 0 0 8 TRACE 0 0 6DAYS
31 28 37+5 2 1 1 0 RH NEGATIVE 1 1 2 2.00PM 18HRS 2HRS 23HRS 0 2 0 0 1 1 22 1 0 STERILE 9DAYS
32 27 38+2 1 0 0 0 PLAC.PREVIA 3 1 1 12.00PM 18HRS 2HRS 27HRS 0 1 0 0 0 0 1 0 0 0 6DAYS
33 25 38+0 4 1 1 2 PREVLSCS 1 4 1 12.00PM 24HRS 2HRS 30HRS 0 1 0 0 0 0 10 TRACE 0 0 5DAYS
34 20 38+1 2 1 1 0 PREVLSCS 1 2 1 9.20AM 24HRS 4HRS 30HRS 0 2 0 0 1 1 15 2 0 STERILE 8DAYS
35 34 37+0 3 1 1 1 IUGR 1 1 2 11.00AM 19HRS 5HRS 31HRS 0 1 0 0 0 0 1 0 0 0 5DAYS
36 25 38+3 3 1 1 1 GDM 1 1 1 11.00AM 21HRS 1HR 28HRS 0 1 0 0 0 0 1 0 0 0 7DAYS
37 30 38+3 2 1 1 0 GDM 1 1 2 12.00PM 22HRS 5HRS 27HRS 0 1 0 0 0 0 0 0 0 0 5DAYS
38 28 37+5 3 1 1 1 PREVLSCS 1 4 1 1.00PM 24HRS 3HRS 29HRS 0 2 0 0 1 1 28 2+ 0 ECOLI 8DAYS
39 30 37+2 2 1 1 0 BREECH 2 4 1 9.30AM 21HRS 1HR 27HRS 0 1 0 0 0 0 1 0 0 0 5DAYS
40 29 38+0 3 2 1 0 PREVLSCS 1 9 1 10.00AM 24HRS 3HRS 30HRS 0 2 0 0 0 0 1 0 0 0 6DAYS
41 29 38+2 1 0 0 0 BREECH 2 2 1 3.00PM 19HRS 4HRS 26HRS 0 3 0 0 1 1 21 1 0 ECOLI 8DAYS
42 31 38+0 5 1 1 3 BREECH 2 1 1 9.00AM 21HRS 5HRS 33HRS 0 2 0 0 0 0 8 TRACE 0 0 7DAYS
43 32 38+6 2 1 1 0 PREVLSCS 1 2 1 10.30AM 20HRS 7HRS 31HRS 0 2 0 0 0 0 4 0 0 0 5DAYS
44 25 38+3 3 0 0 2 IUGR 3 1 2 11.00AM 23HRS 7HRS 27HRS 0 1 0 0 0 0 2 0 0 0 6DAYS
45 23 39+0 1 0 0 0 BREECH 2 1 2 8.30AM 21HRS 5HRS 30HRS 0 2 0 0 0 0 6 0 0 0 5DAYS
46 26 39+2 4 1 1 2 GDM 1 1 1 11.30AM 24HRS 2HRS 34HRS 0 1 0 0 0 0 2 0 0 0 6DAYS
47 29 38+3 1 0 0 0 BREECH 2 2 1 10.00AM 18HRS 2HRS 30HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
48 30 38+4 3 1 0 1 BOH 1 1 2 11.00AM 24HRS 2HRS 31HRS 0 1 0 0 0 0 0 0 0 0 5DAYS
49 28 37+6 2 1 1 0 PREVLSCS 1 4 1 11.00AM 21HRS 2HRS 29HRS 0 2 0 0 0 0 8 0 0 0 6DAYS
50 32 38+1 2 1 1 1 PREVLSCS 1 1 1 10.00AM 19HRS 2HRS 28HRS 0 2 0 1 1 1 22 2 0 ECOLI 8DAYS
51 36 38+4 2 1 1 0 PREVLSCS 1 2 1 9.30AM 21HRS 3HRS 26HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
edpstat:
1-with comfortable
2-mild discomfort
3-significant comfort
 
 
 
 
 
 
 
 
 
 
 
 
 
 
52 26 38+0 4 1 1 2 PREVLSCS 1 1 1 1.00PM 24HRS 2HRS 28HRS 0 2 0 0 0 1 4 0 0 0 6DAYS
53 27 38+0 2 1 1 0 PREVLSCS 1 1 1 11.00AM 24HRS 1HR 30HRS 0 3 0 0 0 1 11 1 0 STERILE 6DAYS
54 31 38+0 2 1 1 0 PREVLSCS 1 4 1 1.00PM 21HRS 5HRS 30HRS 0 2 0 0 0 0 3 0 0 0 5DAYS
55 26 38+3 2 1 1 0 GDM 1 5 1 11.OOAM 23HRS 6HRS 34HRS 0 1 0 0 0 0 5 TRACE 0 0 6DAYS
56 27 37+3 2 0 0 1 IUGR 3 4 2 11.30AM 24HRS 1HR 30HRS 0 3 0 1 1 1 8 1 0 STERILE 8DAYS
57 29 38+0 4 1 1 2 PREVLSCS 1 0 1 9.00AM 21HRS 4HRS 30HRS 0 3 0 0 0 1 11 1+ 0 STERILE 6DAYS
58 23 38+2 2 1 1 0 PREVLSCS 1 2 1 10.00AM 23HRS 4HRS 29HRS 0 1 0 0 0 0 3 0 0 0 5DAYS
59 26 38+0 3 1 1 1 PREVLSCS 1 0 1 9.00AM 23HRS 3HRS 30HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
60 28 37+3 1 0 0 0 BREECH 2 2 1 11.00AM 23HRS 5HRS 31HRS 0 1 0 0 0 0 0 0 0 0 5DAYS
61 31 38+3 2 1 1 0 PREVLSCS 1 1 2 9.30AM 21HRS 4HRS 28HRS 0 2 0 0 0 1 8 1 0 STERILE 6DAYS
62 26 38+4 2 1 0 0 PREVLSCS 1 1 1 8.00AM 22HRS 1HR 27HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
63 27 38+0 1 0 0 0 BREECH 2 1 1 1.30PM 18HRS 2HRS 29HRS 0 1 0 0 0 0 1 0 0 0 5DAYS
64 22 38+0 2 1 1 0 PREVLSCS 1 2 1 10.00AM 23HRS 6HRS 34HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
65 30 37+0 1 0 0 0 TWIN 3 2 1 1.00PM 24HRS 2HRS 29HRS 0 1 0 0 0 0 2 0 0 0 7DAYS
66 29 38+5 2 1 1 0 PREVLSCS 1 5 2 10.00AM 18HRS 2HRS 30HRS 0 3 0 0 0 0 6 0 0 0 5DAYS
67 24 39+0 1 0 0 0 BREECH 2 4 1 10.00AM 17HRS 4HRS 30HRS 0 1 0 0 0 0 8 0 0 0 6DAYS
68 30 38+1 2 1 1 0 PREVLSCS 1 3 1 11.00AM 23HRS 5HRS 31HRS 0 2 0 0 0 0 4 0 0 0 5DAYS
69 23 38+6 3 1 1 1 RH NEGATIVE 1 3 2 10.00AM 19HRS 2HRS 28HRS 0 2 0 0 0 0 15 1 0 STERILE 6DAYS
70 29 38+1 3 1 1 1 PREVLSCS 1 7 1 9.00AM 22HRS 1HR 27HRS 0 2 0 0 0 0 4 0 0 0 5DAYS
71 33 38+3 2 1 1 0 PREVLSCS 1 5 1 8.00AM 22HRS 1HR 27HRS 0 1 0 0 0 0 0 0 0 0 4DAYS
72 31 39+2 1 0 0 0 BREECH 2 3 2 9.30AM 21HRS 4HRS 28HRS 0 1 0 0 0 0 9 0 0 0 6DAYS
73 33 38+2 3 1 1 1 PREVLSCS 1 2 1 1.00PM 24HRS 1HR 27HRS 0 2 0 0 0 0 5 0 0 0 5DAYS
74 23 38+1 2 1 1 0 PREVLSCS 1 1 1 12.OOPM 22HRS 5HRS 27HRS 0 1 0 0 0 0 7 0 0 0 6DAYS
75 27 39+3 2 1 1 0 PREVLSCS 1 7 1 11.00AM 23HRS 5HRS 31HRS 0 1 0 0 0 0 9 0 0 0 5DAYS
76 29 37+1 3 1 1 1 TRANS.LIE 3 6 1 9.00AM 21HRS 4HRS 30HRS 0 3 0 0 0 1 11 1+ 0 STERILE 7DAYS
77 23 38+2 2 1 1 0 PREVLSCS 1 2 1 10.00AM 23HRS 4HRS 29HRS 0 1 0 0 0 0 3 0 0 0 5DAYS
78 26 38+0 2 1 1 0 PREVLSCS 1 0 1 9.00AM 23HRS 3HRS 30HRS 0 1 0 0 0 0 0 0 0 0 5DAYS
79 23 37+5 2 1 1 0 IUGR 1 7 2 10.00AM 23HRS 6HRS 34HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
80 27 38+2 1 0 0 0 TWIN 3 8 1 1.00PM 24HRS 1HR 27HRS 0 2 0 0 0 0 6 0 0 0 6DAYS
81 25 38+0 2 1 1 0 PREVLSCS 1 7 1 9.30AM 21HRS 4HRS 28HRS 0 1 0 0 0 0 9 0 0 0 5DAYS
82 30 38+1 2 1 1 0 GDM 1 4 1 10.00AM 19HRS 2HRS 28HRS 0 2 0 0 0 1 2 0 0 0 6DAYS
83 35 38+3 3 1 1 1 RH NEGATIVE 1 7 1 8.00AM 22HRS 1HRS 27HRS 0 2 0 0 1 0 9 0 0 0 6DAYS
84 22 37+3 2 1 0 0 PREVLSCS 1 8 1 11.30AM 21HRS 4HRS 30HRS 0 1 0 0 0 0 0 0 0 0 5DAYS
85 29 38+2 4 1 1 2 HYPOTHYROID 1 2 1 1.00PM 24HRS 2HRS 29HRS 0 1 0 0 0 0 2 0 0 0 6DAYS
86 29 38+5 2 1 1 0 TWIN 3 5 1 2.00PM 21HRS 6HRS 34HRS 0 2 0 0 1 1 3 0 0 0 6DAYS
87 30 39+3 1 0 0 0 BREECH 2 0 2 8.00AM 22HRS 1HR 27HRS 0 1 0 0 0 0 9 0 0 0 5DAYS
88 26 37+5 2 1 1 0 PREVLSCS 1 9 1 9.00AM 21HRS 3HRS 29HRS 0 1 0 0 0 0 21 2 0 STERILE 6DAYS
89 33 38+3 2 1 1 0 PREVLSCS 1 4 1 11.00AM 23HRS 5HRS 31HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
90 36 38+6 4 1 1 2 PREVLSCS 1 8 1 10.30AM 23HRS 6HRS 34HRS 0 2 0 0 0 0 4 0 0 0 6DAYS
91 24 39+5 1 0 0 0 BREECH 2 1 1 8.00AM 22HRS 1HR 27HRS 0 1 0 0 0 0 3 0 0 0 5DAYS
92 26 38+2 2 1 1 0 PREVLSCS 1 0 1 9.30AM 21HRS 4HRS 28HRS 0 1 0 0 0 0 2 0 0 0 6DAYS
93 27 38+0 3 1 1 1 PREVLSCS 1 0 2 10.00AM 23HRS 6HRS 34HRS 0 1 0 0 0 0 5 0 0 0 5DAYS
94 23 38+5 2 1 1 0 GDM 1 1 1 9.00AM 23HRS 1HR 29HRS 0 1 0 0 0 0 7 0 0 0 5DAYS
95 22 39+2 1 0 0 0 TRANS.LIE 3 4 1 2.00PM 18HRS 2HRS 25HRS 0 1 0 0 0 1 1 0 0 0 6DAYS
96 31 38+5 2 1 1 0 PREVLSCS 1 1 1 8.00AM 22HRS 7HRS 32HRS 0 1 0 0 0 0 2 0 0 0 5DAYS
97 24 38+2 2 1 1 0 IUGR 1 0 2 9.30AM 21HRS 4HRS 28HRS 0 1 0 0 0 0 4 0 0 0 5DAYS
98 31 37+1 4 1 1 2 TRANS.LIE 3 8 1 8.00AM 22HRS 3HRS 29HRS 0 2 0 0 0 0 6 0 0 0 6DAYS
99 27 38+2 2 1 1 1 PREVLSCS 1 7 1 1.00AM 24HRS 1HR 27HRS 0 2 0 0 0 0 5 0 0 0 5DAYS
100 23 39 1 0 0 0 PLAC.PREVIA 3 3 1 10.00AM 19HRS 2HRS 25HRS 0 1 0 0 0 1 8 0 0 0 5DAYS
